Olanzapine and Autism Ranking:

Studies and Trials

This section provides details of scientific studies into the effectiveness of this intervention for people with autism which have been published in English-language, peer-reviewed journals. 

If you know of any other publications we should list on this page please email info@informationautism.org

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.

Related Studies and Trials

• Fido A., Al-Saad S. (2008) Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Kuwait. Medical Principles and Practice. 17(5), Read Abstract (New Window)
  
  
• Hollander E. et al. (2006) A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder Journal of Child and Adolescent Psychopharmacology. 16 Read Abstract (New Window)
  
  
• Horrigan J. P., Barnhill L. J., Courvoisie H. E. (1997) Olanzapine in PDD. Journal of the American Academy of Child and Adolescent Psychiatry.
  
  
• Kemner C. et al. (2002) Open-label study of olanzapine in children with pervasive developmental disorder. Journal of Clinical Psychopharmacology. 22 Read Abstract (New Window)
  
  
• Malek-Ahmadi P., Simonds J. (1998) Olanzapine for autistic disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry. 37(9), Read Abstract (New Window)
  
  
• Malone R. P. et al. (2001) Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. Journal of the American Academy of Child and Adolescent Psychiatry. 40 Read Abstract (New Window)
  
  
• Myers S. M. (2007) The status of pharmacotherapy for autism spectrum disorders. Expert Opinion on Pharmacotherapy. 8(11), Read Abstract (New Window)
  
  
• Potenza M. et al. (1999) Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. Journal of Clinical Psychopharmacology. 19(1), Read Abstract (New Window)
  
  
• Stavrakaki C., Antochi R., Emery P. C. (2004) Olanzapine in the treatment of pervasive developmental disorders: a case series analysis. Journal of Psychiatry and Neuroscience. 29(1), Read Full (New Window)
  
  
• Tan Q. et al. (2006) Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clinical Neuropharmacology. 29(3), Read Abstract (New Window)
  
  

Updated

17 Jun 2022

Last Review

01 Feb 2016

Next Review

01 Feb 2019